Fulton Bank N.A. Sells 2,307 Shares of Avantor, Inc. (NYSE:AVTR)

Fulton Bank N.A. lessened its stake in Avantor, Inc. (NYSE:AVTR) by 15.8% in the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 12,272 shares of the company’s stock after selling 2,307 shares during the quarter. Fulton Bank N.A.’s holdings in Avantor were worth $260,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Versant Capital Management Inc raised its stake in Avantor by 2,003.6% in the second quarter. Versant Capital Management Inc now owns 1,157 shares of the company’s stock valued at $25,000 after purchasing an additional 1,102 shares in the last quarter. Fifth Third Bancorp raised its stake in Avantor by 125.3% in the fourth quarter. Fifth Third Bancorp now owns 1,248 shares of the company’s stock valued at $28,000 after purchasing an additional 694 shares in the last quarter. Livforsakringsbolaget Skandia Omsesidigt raised its stake in Avantor by 565.5% in the fourth quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 1,331 shares of the company’s stock valued at $30,000 after purchasing an additional 1,131 shares in the last quarter. Gladius Capital Management LP acquired a new position in Avantor in the fourth quarter valued at about $42,000. Finally, Montag A & Associates Inc. acquired a new position in Avantor in the fourth quarter valued at about $43,000. Institutional investors and hedge funds own 95.08% of the company’s stock.

Insider Activity at Avantor

In related news, insider Christophe Couturier 10,000 shares of the stock in a transaction on Tuesday, July 30th. The was disclosed in a filing with the SEC, which is available through the SEC website. 1.50% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

AVTR has been the subject of several research analyst reports. Stifel Nicolaus boosted their target price on Avantor from $27.00 to $28.00 and gave the stock a “buy” rating in a research note on Monday, July 29th. TD Cowen boosted their target price on Avantor from $28.00 to $31.00 and gave the stock a “buy” rating in a research note on Monday, July 29th. Royal Bank of Canada reissued an “outperform” rating and set a $31.00 target price on shares of Avantor in a research note on Monday, July 29th. Evercore ISI lowered their target price on Avantor from $28.00 to $27.00 and set an “outperform” rating for the company in a research note on Tuesday, July 2nd. Finally, Barclays boosted their target price on Avantor from $25.00 to $28.00 and gave the stock an “overweight” rating in a research note on Monday, July 29th. Four investment analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $27.21.

Avantor Trading Up 0.8 %

Shares of Avantor stock traded up $0.21 on Tuesday, hitting $25.16. The stock had a trading volume of 6,757,728 shares, compared to its average volume of 7,127,365. The stock has a 50 day moving average of $22.61 and a 200 day moving average of $23.83. Avantor, Inc. has a twelve month low of $16.63 and a twelve month high of $28.00. The company has a debt-to-equity ratio of 0.89, a quick ratio of 1.05 and a current ratio of 1.59. The firm has a market capitalization of $17.10 billion, a P/E ratio of 64.50, a PEG ratio of 2.71 and a beta of 1.32.

Avantor Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.